Sandoz’ Goldschmidt is lined up as Stada chief
Peter Goldschmidt, president of Sandoz’ US subsidiary and head of the North America region, will succeed Claudio Albrecht as chief executive officer (CEO) of Stada from 1 September 2018, the German firm has announced. “Goldschmidt will build on the successful course of renewal and growth at Stada which Claudio Albrecht will continue pursuing until the transition of the CEO role,” the company stated, adding that “as previously announced, Albrecht will then move on to a non-executive position within the group”.
You may also be interested in...
Novartis has appointed its former global head of M&A, Keren Haruvi, to take over from Carol Lynch as president of Sandoz US and head of North America.
The Cincinnati, OH-based firm will pay $8m to recompense Unites States residents who purchased aerosol personal-care products potentially contaminated with benzene over a roughly six-year period.
An independent review of the US FDA’s food regulatory programs could renew a debate over splitting FDA into two agencies. That could be a distraction for the agency in the coming year – but it could also help keep the medical product review groups out of the political hot seat.